Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/17 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 121
- 較 2021 年第 1 季 −37
- 總值
- $10.5 億
- 較 2021 年第 1 季 −$3,744 萬 (−3.4%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | 1,147,673 | $6,875 萬 | 6.5% | +187,200+19.5% | 加碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 405,608 | $6,682 萬 | 6.4% | −48,292−10.6% | 減碼 | 歷史 |
| MRKMerck & Co., Inc. | Stock | 772,601 | $6,009 萬 | 5.7% | −36,207−4.5% | 減碼 | 歷史 |
| SNYSanofi | SPONSORED ADR | 843,400 | $4,441 萬 | 4.2% | −154,500−15.5% | 減碼 | 歷史 |
| GNRCGenerac Holdings Inc. | Stock | 104,363 | $4,333 萬 | 4.1% | −1,300−1.2% | 減碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 181,895 | $4,175 萬 | 4.0% | −247,305−57.6% | 減碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 366,194 | $4,125 萬 | 3.9% | −233,306−38.9% | 減碼 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 518,611 | $1,962 萬 | 1.9% | +21,475+4.3% | 加碼 | 歷史 |
| NICENICE Ltd. | SPONSORED ADR | 76,786 | $1,900 萬 | 1.8% | +37,305+94.5% | 加碼 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 648,303 | $1,852 萬 | 1.8% | +179,062+38.2% | 加碼 | 歷史 |
| KRNTKornit Digital Ltd. | SHS | 147,793 | $1,838 萬 | 1.7% | −588−0.4% | 減碼 | 歷史 |
| MSFTMicrosoft Corp | Stock | 67,536 | $1,830 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 868,886 | $1,812 萬 | 1.7% | +151,135+21.1% | 加碼 | 歷史 |
| ZLABZai Lab Ltd | ADR | 97,946 | $1,734 萬 | 1.6% | +32,158+48.9% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 195,117 | $1,608 萬 | 1.5% | +57,445+41.7% | 加碼 | 歷史 |
| FATEFate Therapeutics Inc | COM | 165,299 | $1,435 萬 | 1.4% | +55,492+50.5% | 加碼 | 歷史 |
| LPSNLiveperson Inc | COM | 225,000 | $1,423 萬 | 1.4% | −35,000−13.5% | 減碼 | 歷史 |
| AMZNAmazon Com Inc | Stock | 4,061 | $1,397 萬 | 1.3% | +1,300+47.1% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 302,965 | $1,360 萬 | 1.3% | +100,831+49.9% | 加碼 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 4,080,673 | $1,285 萬 | 1.2% | −96,485−2.3% | 減碼 | 歷史 |
| AUDCAudiocodes Ltd | ORD | 385,194 | $1,275 萬 | 1.2% | −90,430−19.0% | 減碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 259,895 | $1,261 萬 | 1.2% | +12,368+5.0% | 加碼 | 歷史 |
| VRNSVaronis Systems Inc | COM | 218,013 | $1,256 萬 | 1.2% | +79,338+57.2% | 加碼 | 歷史 |
| ONCROncorus, Inc. | COM | 893,548 | $1,233 萬 | 1.2% | −9,563−1.1% | 減碼 | 歷史 |
| HOWLWerewolf Therapeutics, Inc. | COM | 706,294 | $1,205 萬 | 1.1% | +706,294 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 634,088 | $1,195 萬 | 1.1% | +349,864+123.1% | 加碼 | 歷史 |
| Affimed N VN01045108 | COM | 1,276,702 | $1,085 萬 | 1.0% | +257,737+25.3% | 加碼 | – |
| ALXOAlx Oncology Holdings Inc | COM | 192,728 | $1,054 萬 | 1.0% | +62,377+47.9% | 加碼 | 歷史 |
| TWLOTwilio Inc | CL A | 26,500 | $1,045 萬 | 1.0% | +26,500 | 新進 | 歷史 |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 1,009,497 | $1,038 萬 | 1.0% | +289,497+40.2% | 加碼 | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 378,642 | $985.2 萬 | 0.9% | +378,642 | 新進 | 歷史 |
| CSTECaesarstone Ltd. | ORD SHS | 644,146 | $950.8 萬 | 0.9% | +108,998+20.4% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 547,187 | $939.5 萬 | 0.9% | −90,906−14.2% | 減碼 | 歷史 |
| METAMeta Platforms, Inc. | Stock | 27,000 | $938.8 萬 | 0.9% | +27,000 | 新進 | 歷史 |
| SEDGSolaredge Technologies, Inc. | COM | 32,200 | $889.9 萬 | 0.8% | +32,200 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 52,550 | $850.8 萬 | 0.8% | +52,550 | 新進 | 歷史 |
| BIIBBiogen Inc. | COM | 23,995 | $830.9 萬 | 0.8% | +17,195+252.9% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 832,878 | $824.5 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 800,000 | $808.0 萬 | 0.8% | +800,000 | 新進 | 歷史 |
| NKTXNkarta, Inc. | COM | 252,478 | $800.1 萬 | 0.8% | +151,472+150.0% | 加碼 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 274,214 | $794.9 萬 | 0.8% | +133,549+94.9% | 加碼 | 歷史 |
| ONTOOnto Innovation Inc. | COM | 107,548 | $785.5 萬 | 0.7% | −17,452−14.0% | 減碼 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 233,135 | $784.7 萬 | 0.7% | +82,406+54.7% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 369,714 | $777.9 萬 | 0.7% | −80,350−17.9% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 47,309 | $764.2 萬 | 0.7% | +17,530+58.9% | 加碼 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 687,900 | $724.4 萬 | 0.7% | 00.0% | 不變 | – |
| ONCBeOne Medicines Ltd. | ADR | 20,900 | $717.3 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 334,794 | $702.7 萬 | 0.7% | +132,810+65.8% | 加碼 | 歷史 |
| VRNTVerint Systems Inc | COM | 150,000 | $676.1 萬 | 0.6% | +150,000 | 新進 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 683,395 | $673.1 萬 | 0.6% | +683,395 | 新進 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 244,157 | $647.7 萬 | 0.6% | +29,081+13.5% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 286,506 | $603.7 萬 | 0.6% | +209,514+272.1% | 加碼 | 歷史 |
| RACBResearch Alliance Corp. II | COM CL A | 600,000 | $600.0 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ORTXOrchard Therapeutics plc | ADS | 1,366,564 | $599.9 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ATERAterian, Inc. | Equity | 399,999 | $585.2 萬 | 0.6% | +399,999 | 新進 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 294,825 | $548.1 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ALLTAllot Ltd. | SHS | 276,187 | $547.7 萬 | 0.5% | −144,018−34.3% | 減碼 | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 173,891 | $537.1 萬 | 0.5% | +6,092+3.6% | 加碼 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $536.0 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| QUREuniQure N.V. | SHS | 172,000 | $529.8 萬 | 0.5% | +172,000 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 801,256 | $524.0 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| FVRRFiverr International Ltd. | ORD SHS | 21,500 | $521.4 萬 | 0.5% | +21,500 | 新進 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 189,083 | $520.4 萬 | 0.5% | +74,440+64.9% | 加碼 | 歷史 |
| CRISCuris Inc | COM NEW | 588,264 | $474.7 萬 | 0.5% | −297,574−33.6% | 減碼 | 歷史 |
| CVRXCVRx, Inc. | COM | 150,000 | $420.0 萬 | 0.4% | +150,000 | 新進 | 歷史 |
| RUNSunrun Inc. | COM | 72,000 | $401.6 萬 | 0.4% | +72,000 | 新進 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 46,350 | $389.1 萬 | 0.4% | −8,612−15.7% | 減碼 | 歷史 |
| SGTXSigilon Therapeutics, Inc. | COM | 360,239 | $386.5 萬 | 0.4% | −2,000−0.6% | 減碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 28,425 | $365.9 萬 | 0.3% | +28,425 | 新進 | 歷史 |
| PLTKPlaytika Holding Corp. | COM | 150,000 | $357.6 萬 | 0.3% | +150,000 | 新進 | 歷史 |
| ARKOARKO Corp. | COM | 369,875 | $339.9 萬 | 0.3% | −38,125−9.3% | 減碼 | 歷史 |
| ANNXAnnexon, Inc. | COM | 148,318 | $333.9 萬 | 0.3% | +148,318 | 新進 | 歷史 |
| Eucrates Biomedical Acqu CorG3141W106 | SHS | 329,025 | $323.9 萬 | 0.3% | +25,000+8.2% | 加碼 | – |
| ISEEIVERIC bio, Inc. | COM | 500,000 | $315.5 萬 | 0.3% | +500,000 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 100,391 | $313.0 萬 | 0.3% | −147,709−59.5% | 減碼 | 歷史 |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 233,850 | $304.0 萬 | 0.3% | +21,250+10.0% | 加碼 | – |
| Bio Green Med Solution, Inc.23254L603 | COM | 508,322 | $300.9 萬 | 0.3% | 00.0% | 不變 | – |
| NEXNNexxen International Ltd. | ADS | 150,000 | $298.5 萬 | 0.3% | +150,000 | 新進 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 227,450 | $295.5 萬 | 0.3% | +133,742+142.7% | 加碼 | 歷史 |
| SSentinelOne, Inc. | CL A | 68,400 | $290.7 萬 | 0.3% | +68,400 | 新進 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 84,074 | $287.2 萬 | 0.3% | +40,718+93.9% | 加碼 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 292,194 | $286.1 萬 | 0.3% | −7,806−2.6% | 減碼 | – |
| ARGXArgenx SE | SPONSORED ADR | 9,249 | $278.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KRROKorro Bio, Inc. | COM | 275,160 | $274.1 萬 | 0.3% | +275,160 | 新進 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 125,000 | $267.5 萬 | 0.3% | +125,000 | 新進 | 歷史 |
| PRGOPERRIGO Co plc | SHS | 52,500 | $240.7 萬 | 0.2% | +52,500 | 新進 | 歷史 |
| TWSTTwist Bioscience Corp | COM | 18,000 | $239.9 萬 | 0.2% | +18,000 | 新進 | 歷史 |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 165,295 | $237.9 萬 | 0.2% | −1,037−0.6% | 減碼 | – |
| IPSCCentury Therapeutics, Inc. | COM | 80,000 | $234.7 萬 | 0.2% | +80,000 | 新進 | 歷史 |
| LVTXLAVA Therapeutics NV | SHS | 215,359 | $234.3 萬 | 0.2% | +1,465+0.7% | 加碼 | 歷史 |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 100,000 | $227.0 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| Turmeric Acquisition CorpG9127T108 | CL A | 219,440 | $217.0 萬 | 0.2% | 00.0% | 不變 | – |
| JYACJiya Acquisition Corp. | COM CL A | 199,028 | $197.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HYPRHyperfine, Inc. | CL A SHS | 200,000 | $197.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Healthcare Capital Corp42228C200 | UNIT 12/31/2025 | 196,610 | $196.2 萬 | 0.2% | −203,390−50.8% | 減碼 | – |
| ALDXAldeyra Therapeutics, Inc. | COM | 150,000 | $170.0 萬 | 0.2% | +150,000 | 新進 | 歷史 |
| WIXWix.com Ltd. | SHS | 5,700 | $165.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 51,000 | $148.5 萬 | 0.1% | +51,000 | 新進 | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM | 53,867 | $148.0 萬 | 0.1% | +53,867 | 新進 | 歷史 |
| Clarim Acquisition Corp18049C207 | UNIT 99/99/9999 | 148,886 | $147.8 萬 | 0.1% | −151,114−50.4% | 減碼 | – |
選擇權（13 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $8,463 萬 | – |
| MRKMerck & Co., Inc. | Stock | $6,009 萬 | – |
| ENPHEnphase Energy, Inc. | Stock | – | $4,224 萬 |
| iShares Tr464287515 | EXPANDED TECH | $4,095 萬 | – |
| State Street Technology Select Sector SPDR ETF81369Y803 | ETF | $3,101 萬 | – |
| iShares Russell 2000 ETF464287655 | ETF | $2,408 萬 | – |
| FVRRFiverr International Ltd. | ORD SHS | – | $1,916 萬 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $1,891 萬 |
| Invesco Exch Traded FD Tr II46138G706 | SOLAR ETF | – | $1,876 萬 |
| BIIBBiogen Inc. | COM | – | $1,731 萬 |
| IONSIonis Pharmaceuticals Inc | COM | – | $744.3 萬 |
| AGIOAgios Pharmaceuticals, Inc. | COM | – | $639.3 萬 |
| ATERAterian, Inc. | Equity | – | $520.2 萬 |
2021 年第 1 季之後清倉（73 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 200,000 | $1,263 萬 | 1.2% | 歷史 |
| PANWPalo Alto Networks Inc | Stock | 32,300 | $1,040 萬 | 1.0% | 歷史 |
| BOLTBolt Biotherapeutics, Inc. | COM | 241,000 | $793.1 萬 | 0.7% | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 175,140 | $759.9 萬 | 0.7% | 歷史 |
| Mohawk Group Hldgs Inc608189106 | COM | 251,015 | $740.5 萬 | 0.7% | – |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 670,459 | $720.1 萬 | 0.7% | – |
| Cyberark Software LtdM2682V108 | SHS | 55,000 | $711.4 萬 | 0.7% | – |
| COGTCogent Biosciences, Inc. | COM | 762,569 | $669.5 萬 | 0.6% | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 258,880 | $665.1 萬 | 0.6% | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 145,476 | $654.1 萬 | 0.6% | 歷史 |
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 400,000 | $551.2 萬 | 0.5% | – |
| BIDUBaidu, Inc. | ADR | 25,000 | $543.9 萬 | 0.5% | 歷史 |
| Rada Electr Inds LtdM81863124 | COM PAR NEW | 407,925 | $489.9 萬 | 0.5% | – |
| Reinvent Technology PartnersG74847107 | SHS CL A | 468,012 | $468.5 萬 | 0.4% | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 220,320 | $453.9 萬 | 0.4% | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 1,312,415 | $442.3 萬 | 0.4% | 歷史 |
| Farfetch Ltd30744W107 | ORD SH CL A | 80,000 | $424.2 萬 | 0.4% | – |
| ORICOric Pharmaceuticals, Inc. | COM | 169,900 | $416.3 萬 | 0.4% | 歷史 |
| Foresight Acquisition Corp34552Y205 | UNIT 01/29/2026 | 420,000 | $416.2 萬 | 0.4% | – |
| IFRXInflaRx N.V. | COM | 1,000,000 | $390.0 萬 | 0.4% | 歷史 |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 1,294,000 | $374.0 萬 | 0.3% | – |
| EWTXEdgewise Therapeutics, Inc. | COM | 100,000 | $325.0 萬 | 0.3% | 歷史 |
| Longview Acquisition Corp. II54319Q204 | UNIT 99/99/9999 | 300,000 | $301.2 萬 | 0.3% | – |
| GRTXGalera Therapeutics, Inc. | COM | 323,348 | $285.2 萬 | 0.3% | 歷史 |
| DMRADamora Therapeutics, Inc. | COM | 448,016 | $272.2 萬 | 0.3% | 歷史 |
| PHASPhaseBio Pharmaceuticals Inc | COM | 750,000 | $259.5 萬 | 0.2% | 歷史 |
| IMVTImmunovant, Inc. | COM | 158,500 | $254.2 萬 | 0.2% | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 244,000 | $247.4 萬 | 0.2% | 歷史 |
| FNCHFinch Therapeutics Group, Inc. | COM | 150,000 | $238.7 萬 | 0.2% | 歷史 |
| CAMTCamtek Ltd | ORD | 79,746 | $238.4 萬 | 0.2% | 歷史 |
| TILInstil Bio, Inc. | COM | 95,000 | $238.3 萬 | 0.2% | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 198,260 | $210.2 萬 | 0.2% | 歷史 |
| Highcape Cap Acquisition Cor42984L105 | COM CL A | 172,396 | $205.5 萬 | 0.2% | – |
| ALITAlight, Inc. / Delaware | COM CL A | 200,000 | $200.8 萬 | 0.2% | 歷史 |
| EQEquillium, Inc. | COM | 254,184 | $181.7 萬 | 0.2% | 歷史 |
| GIGCAPITAL4 Inc37518G200 | UNIT 99/99/9999 | 175,000 | $172.7 萬 | 0.2% | – |
| Starboard Value Acquisitn Co85521J109 | COM CL A | 170,937 | $169.7 萬 | 0.2% | – |
| Pieris Pharmaceuticals Inc720795103 | COM | 650,000 | $167.1 萬 | 0.2% | – |
| KDNYChinook Therapeutics, Inc. | COM | 101,666 | $158.0 萬 | 0.1% | 歷史 |
| NSTBNorthern Star Investment Corp. II | COM CLASS A | 155,367 | $155.4 萬 | 0.1% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 70,000 | $154.0 萬 | 0.1% | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 36,000 | $153.3 萬 | 0.1% | 歷史 |
| Forum Merger IV Corp349875203 | UNIT 03/15/2028 | 150,000 | $148.5 萬 | 0.1% | – |
| Landcadia Holdings IV, Inc.51477A203 | UNIT 05/01/2025 | 150,000 | $148.5 萬 | 0.1% | – |
| Alkuri Global Acquisition Corp.66981N202 | UNIT 01/01/2028 | 150,000 | $148.2 萬 | 0.1% | – |
| BBIOBridgeBio Pharma, Inc. | COM | 23,890 | $147.2 萬 | 0.1% | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 100,000 | $146.1 萬 | 0.1% | 歷史 |
| GMDAGamida Cell Ltd. | SHS | 178,450 | $144.4 萬 | 0.1% | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 5,530 | $118.8 萬 | 0.1% | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 100,000 | $112.3 萬 | 0.1% | 歷史 |
| Revolution Accelertn Acqu Co76156P106 | COM CL A | 109,994 | $111.5 萬 | 0.1% | – |
| SWBKSwitchback II Corp | COM CL A | 103,698 | $101.9 萬 | 0.1% | 歷史 |
| Falcon Capital Acquisitn Cor30606L108 | COM CL A | 100,010 | $99.7 萬 | 0.1% | – |
| Mcap Acquisition Corp55282T208 | UNIT 02/18/2030 | 100,000 | $99.5 萬 | 0.1% | – |
| VPC Impact Acqu Holdi III IN91835J207 | UNIT 99/99/9999 | 100,000 | $98.7 萬 | 0.1% | – |
| VPC Impact Acquisition HldgG9460L100 | UNIT 03/05/2026 | 100,000 | $98.6 萬 | 0.1% | – |
| 890 5th Ave Partners Inc28250A204 | UNIT 01/12/2026 | 98,828 | $98.3 萬 | 0.1% | – |
| CNTBConnect Biopharma Holdings Ltd | ADS | 50,000 | $92.5 萬 | 0.1% | 歷史 |
| Glass Houses Acquisition Cor37714P202 | UNIT 03/25/2028 | 89,884 | $90.2 萬 | 0.1% | – |
| NVMINova Ltd. | COM | 8,556 | $77.9 萬 | 0.1% | 歷史 |
| Live Oak Mobility Acquisi Co538126202 | UNIT 03/01/2028 | 75,000 | $74.9 萬 | 0.1% | – |
| LABPLandos Biopharma, Inc. | COM | 70,000 | $67.4 萬 | 0.1% | 歷史 |
| Spartan Acquisition Corp II846775104 | COM | 50,000 | $52.3 萬 | <0.1% | – |
| Vectoiq Acquisition Corp II92244F208 | UNIT 99/99/9999 | 50,000 | $50.7 萬 | <0.1% | – |
| Stratim Cloud Acquisition Corp.86309R206 | UNIT 03/05/2026 | 50,000 | $50.0 萬 | <0.1% | – |
| Z-Work Acquisition Corp98880C201 | UNIT 99/99/9999 | 50,000 | $49.8 萬 | <0.1% | – |
| EJF Acquisition Corp.G2955B117 | UNIT 03/10/2026 | 49,900 | $49.7 萬 | <0.1% | – |
| Agile Growth Corp.G01202129 | UNIT 03/09/2026 | 50,000 | $49.6 萬 | <0.1% | – |
| MDH Acquisition Corp55283P205 | UNIT 99/99/9999 | 31,000 | $30.8 萬 | <0.1% | – |
| CM Life Sciences Inc18978W109 | COM CL A | 20,000 | $29.8 萬 | <0.1% | – |
| Noble Rock Acquisition CorpG6546R127 | UNIT 01/31/2028 | 28,000 | $27.7 萬 | <0.1% | – |
| Fintech Evolution Acquis GroG3R19A112 | UNIT 99/99/9999 | 25,000 | $24.7 萬 | <0.1% | – |
| NBSENeuBase Therapeutics, Inc. | COM | 31,900 | $23.6 萬 | <0.1% | 歷史 |